Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Tests in secondary care to identify people at high risk of ovarian cancer

NICE guidanceNICE · 2017NICE guidance

Summary (source: NICE)
Reference: HTG453
Type: NICE guidance
Published: 15 November 2017
Issued by: National Institute for Health and Care Excellence (NICE)
Full guidance: Read on nice.org.uk →

Tests in secondary care to identify people at high risk of ovarian cancer is nice guidance HTG453, issued by the National Institute for Health and Care Excellence (NICE), which produces evidence-based recommendations for health and care in England.

Note: NICE guidance is published under a licence that applies to the UK and does not permit republication of the full text. This page provides the reference and a direct link to the official document. Read the full guidance on nice.org.uk →
Document official

Page NICE

Official summary published by the National Institute for Health and Care Excellence (nice.org.uk), last published 15 November 2017. Indicative information for healthcare professionals — refer to the full document. Reference and link only, per NICE licence.
Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →